Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers

作者: Carlee E. Ashley , Eric C. Carnes , Katharine E. Epler , David P. Padilla , Genevieve K. Phillips

DOI: 10.1021/NN204102Q

关键词:

摘要: The therapeutic potential of small interfering RNAs (siRNAs) is severely limited by the availability delivery platforms that protect siRNA from degradation, deliver it to target cell with high specificity and efficiency, promote its endosomal escape cytosolic dispersion. Here we report mesoporous silica nanoparticle-supported lipid bilayers (or "protocells") exhibit multiple properties overcome many limitations existing platforms. Protocells have a 10- 100-fold greater capacity for than corresponding nanoparticles are markedly more stable when incubated under physiological conditions. loaded cocktail siRNAs bind cells in manner dependent on presence an appropriate targeting peptide and, through endocytic pathway followed disruption, silencing nucleotides cytoplasm. expression each genes targeted was shown be repressed at protein level, resulting potent induction growth arrest apoptosis. Incubation control lack antigen recognized siRNA-loaded protocells induced neither repression nor apoptosis, indicating precise cytotoxic activity. In terms loading capacity, capabilities, potency action, provide unique attributes as platform oligonucleotides.

参考文章(61)
B. Ozpolat, A. K. Sood, G. Lopez-Berestein, Nanomedicine based approaches for the delivery of siRNA in cancer Journal of Internal Medicine. ,vol. 267, pp. 44- 53 ,(2010) , 10.1111/J.1365-2796.2009.02191.X
Tian-Meng Sun, Jin-Zhi Du, Yan-Dan Yao, Cheng-Qiong Mao, Shuang Dou, Song-Yin Huang, Pei-Zhuo Zhang, Kam W Leong, Er-Wei Song, Jun Wang, None, Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression ACS Nano. ,vol. 5, pp. 1483- 1494 ,(2011) , 10.1021/NN103349H
Kathryn A. Whitehead, Robert Langer, Daniel G. Anderson, Knocking down barriers: advances in siRNA delivery Nature Reviews Drug Discovery. ,vol. 8, pp. 129- 138 ,(2009) , 10.1038/NRD2742
Takemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, René Nieves-Alicea, Aman P Mann, Edna Mora, Hee-Dong Han, Mian MK Shahzad, Xuewu Liu, Rohan Bhavane, Jianhua Gu, Jean R Fakhoury, Ciro Chiappini, Chunhua Lu, Koji Matsuo, Biana Godin, Rebecca L Stone, Alpa M Nick, Gabriel Lopez-Berestein, Anil K Sood, Mauro Ferrari, None, Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles Cancer Research. ,vol. 70, pp. 3687- 3696 ,(2010) , 10.1158/0008-5472.CAN-09-3931
Beverly L. Davidson, Paul B. McCray, Current prospects for RNA interference-based therapies Nature Reviews Genetics. ,vol. 12, pp. 329- 340 ,(2011) , 10.1038/NRG2968
Yunching Chen, Xiaodong Zhu, Xiaoju Zhang, Bin Liu, Leaf Huang, Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Molecular Therapy. ,vol. 18, pp. 1650- 1656 ,(2010) , 10.1038/MT.2010.136
Juewen Liu, Alison Stace-Naughton, C. Jeffrey Brinker, Silica nanoparticle supported lipid bilayers for gene delivery Chemical Communications. pp. 5100- 5102 ,(2009) , 10.1039/B911472F
Robby A. Petros, Joseph M. DeSimone, Strategies in the design of nanoparticles for therapeutic applications Nature Reviews Drug Discovery. ,vol. 9, pp. 615- 627 ,(2010) , 10.1038/NRD2591
Nicole M. Moore, Clayton L. Sheppard, Tiffany R. Barbour, Shelly E. Sakiyama-Elbert, The effect of endosomal escape peptides onin vitrogene delivery of polyethylene glycol-based vehicles The Journal of Gene Medicine. ,vol. 10, pp. 1134- 1149 ,(2008) , 10.1002/JGM.1234
Monica R. Lares, John J. Rossi, Dominique L. Ouellet, RNAi and small interfering RNAs in human disease therapeutic applications Trends in Biotechnology. ,vol. 28, pp. 570- 579 ,(2010) , 10.1016/J.TIBTECH.2010.07.009